| scholarly article | Q13442814 |
| P2093 | author name string | Rene J Duquesnoy | |
| Marilyn Marrari | |||
| P2860 | cites work | Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones | Q28610595 |
| The effect of HLA-C matching on acute renal transplant rejection | Q33931420 | ||
| A structurally based approach to determine HLA compatibility at the humoral immune level | Q36316220 | ||
| The binding site of NK receptors on HLA-C molecules | Q41124291 | ||
| Sharing kidneys across donor-service area boundaries with sensitized candidates can be influenced by HLA C. | Q42643050 | ||
| HLAMatchmaker-based analysis of human monoclonal antibody reactivity demonstrates the importance of an additional contact site for specific recognition of triplet-defined epitopes | Q42665365 | ||
| New HLA class I epitopes defined by murine monoclonal antibodies | Q46616953 | ||
| The number of amino acid triplet differences between patient and donor is predictive for the antibody reactivity against mismatched human leukocyte antigens | Q47683551 | ||
| Reassessing the impact of donor HLA-C genotype on long-term liver transplant survival | Q47946752 | ||
| Impact of recipient HLA-C in liver transplant: a protective effect of HLA-Cw*07 on acute rejection. | Q50709507 | ||
| Human Monoclonal Antibody Reactivity With Human Leukocyte Antigen Class I Epitopes Defined by Pairs of Mismatched Eplets and Self-Eplets | Q51639128 | ||
| How did a patient who types for HLA-B*4403 develop antibodies that react with HLA-B*4402? | Q51771495 | ||
| Correlations between Terasaki's HLA class I epitopes and HLAMatchmaker-defined eplets on HLA-A, -B and -C antigens. | Q51824278 | ||
| Predicting the immunogenicity of human leukocyte antigen class I alloantigens using structural epitope analysis determined by HLAMatchmaker. | Q51874425 | ||
| The number of amino acid residues mismatches correlates with flow cytometry crossmatching results in high PRA renal patients. | Q52041496 | ||
| Impact of HLA-C and Bw epitopes disparity on liver transplantation outcome. | Q53630152 | ||
| Donor HLA-C Genotype Has a Profound Impact on the Clinical Outcome Following Liver Transplantation | Q61796622 | ||
| Rejection of a kidney graft mismatched only for the HLA-C locus and an HLA-BW22 split | Q70563664 | ||
| Generation of HLA-C-specific cytotoxic T cells in association with marrow graft rejection: analysis of alloimmunity by T-cell cloning and testing of T-cell-receptor rearrangements | Q74444944 | ||
| KIR/HLA ligand incompatibility in kidney transplantation | Q80228070 | ||
| Human leukocyte antigen class I epitopes: update to 103 total epitopes, including the C locus | Q80829482 | ||
| Detection of donor-specific HLA antibodies before and after removal of a rejected kidney transplant | Q82343270 | ||
| P433 | issue | 3 | |
| P921 | main subject | antibody | Q79460 |
| P304 | page(s) | 164-171 | |
| P577 | publication date | 2010-12-24 | |
| P1433 | published in | Transplant Immunology | Q15758510 |
| P1476 | title | Detection of antibodies against HLA-C epitopes in patients with rejected kidney transplants. | |
| P478 | volume | 24 |
| Q89622142 | A curious case of de novo anti-HLA-C antibody-mediated humoral rejection and Fabry-like zebra bodies in a renal transplant recipient |
| Q39720454 | Acute antibody-mediated renal allograft rejection associated with HLA-Cw17 antibody. |
| Q39612344 | Allelic and Epitopic Characterization of Intra-Kidney Allograft Anti-HLA Antibodies at Allograft Nephrectomy. |
| Q50853819 | Antibody-reactive class I epitopes defined by pairs of mismatched eplets and self-eplets. |
| Q37853627 | Antibody-reactive epitope determination with HLAMatchmaker and its clinical applications |
| Q38441533 | Chronic active antibody mediated rejection associated with human leukocyte antigen-C*07 antibodies |
| Q39015291 | Clinical and immunological relevance of antibodies in solid organ transplantation |
| Q47563660 | Desensitisation strategies in high-risk children before kidney transplantation. |
| Q33754516 | Evaluation of the humoral immune response to human leukocyte antigens in Brazilian renal transplant candidates |
| Q51091761 | HLA epitope based matching for transplantation. |
| Q39456025 | HLA-B*15:33, a rare allele whose product reacts as an HLA-B62 and -Cw5/Cw8 specificity. |
| Q42044561 | Humoral alloimmunity in transplantation: relevance of HLA epitope antigenicity and immunogenicity |
| Q38341785 | Humoral immunity in renal transplantation: epitopes, Cw and DP, and complement-activating capability--an update |
| Q37522592 | Impact of preformed donor-specific antibodies against HLA class I on kidney graft outcomes: Comparative analysis of exclusively anti-Cw vs anti-A and/or -B antibodies |
| Q46322442 | Kidney intragraft donor-specific antibodies as determinant of antibody-mediated lesions and poor graft outcome |
| Q38007085 | Luminex and antibody detection in kidney transplantation |
| Q44940106 | Positive C4d immunostaining of placental villous syncytiotrophoblasts supports host-versus-graft rejection in villitis of unknown etiology |
| Q28069627 | Reflections on HLA Epitope-Based Matching for Transplantation |
| Q40925162 | Sensitization trends after renal allograft failure: the role of DQ eplet mismatches in becoming highly sensitized |
| Q26774993 | The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant Recipients |
Search more.